PCYC Insider Trading Activity and SEC Form 4 Filings
PCYC insider trading summary
No open-market insider purchases or sales of Pharmacyclics Inc (PCYC) have been reported on SEC Form 4 in the past 12 months.
Latest PCYC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 13, 2015 | Manmeet Singh Soni | Chief Financial Officer | Sell | $641K (2,514 @ $254.91) |
| Mar 13, 2015 | Manmeet Singh Soni | Chief Financial Officer | Sell | $230K (902 @ $254.88) |
| Mar 12, 2015 | Heow Tan | Chief Quality&Tech Operations | Sell | $255K (1,000 @ $254.51) |
| Mar 11, 2015 | Maky Zanganeh | Chief Operating Officer | Sell | $7.6M (30,000 @ $254.11) |
| Mar 11, 2015 | Manmeet Singh Soni | Chief Financial Officer | Sell | $6.1M (24,098 @ $254.15) |
| Nov 13, 2014 | Maria Fardis | Chief of Oncology Ops & Allian | Sell | $424K (3,000 @ $141.30) |
| Nov 13, 2014 | Manmeet Singh Soni | Chief Financial Officer | Sell | $141K (1,000 @ $141.44) |
| Nov 12, 2014 | Maky Zanganeh | Chief Operating Officer | Sell | $728K (5,273 @ $138.01) |
| Nov 12, 2014 | Maky Zanganeh | Chief Operating Officer | Sell | $90K (658 @ $137.50) |
| Nov 10, 2014 | Richard B Love | General Counsel | Sell | $201K (1,500 @ $133.87) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.